Search - tctmd.com

Displaying 301 - 320 of 548

Sort: Relevancy | Date

News Conference News ACC 2022

Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term

Shelley Wood

April 03, 2022

SODIUM-HF: No Impact of Dietary Salt Restriction on Death or Hospitalization

News Conference News ACC 2022

SODIUM-HF: No Impact of Tighter Dietary Salt Restriction on Death or Hospitalization

L.A. McKeown

April 02, 2022

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

News Opinion CV Team Dispatch

April 2022 News Roundup

L.A. McKeown

April 01, 2022

News Daily News

A ‘Call to Action’ for HF Trials: More Black, Hispanic Patients

Caitlin E. Cox

March 31, 2022

News Daily News

Prognosis of Myocarditis Following COVID-19 Vaccination ‘Favorable’

Michael O'Riordan

March 28, 2022

News Daily News

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

L.A. McKeown

March 22, 2022

News Daily News

Heart Transplant Recipients Fare Poorer When Stroke Is Cause of Death for Younger Donors

Yael L. Maxwell

March 17, 2022

News Daily News

Guideline-Directed Therapies Underused in Frail HF Patients

L.A. McKeown

March 11, 2022

News Opinion CV Team Dispatch

March 2022 News Roundup

L.A. McKeown

March 01, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2022

Shelley Wood

February 28, 2022

News Daily News

FDA Approves Empagliflozin for Treatment of HFpEF

Michael O'Riordan

February 24, 2022

News Conference News THT 2022

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

L.A. McKeown

February 07, 2022

News Conference News THT 2022

PA Pressure Monitoring Useful Even in Presymptomatic CHF Patients

L.A. McKeown

February 03, 2022

News Conference News THT 2022

Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size

Shelley Wood

February 02, 2022

Presentation THT 2022

Hemodynamic Profiles Across the Range of Left Ventricular Ejection Fraction in Heart Failure With Preserved Ejection Fraction – Potential Therapeutic Implications

Presenter: Sebastian Rosch

February 02, 2022

News Industry News

Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients

February 02, 2022

Presentation THT 2022

The Effect of Rhythm vs. Rate Control for Atrial Fibrillation on Mortality and Hospitalization in Patients With Heart Failure With Preserved Ejection Fraction: Updated Meta-Analysis

Presenter: Mohammed Al-Sadawi

February 01, 2022

News Conference News THT 2022

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Shelley Wood

February 01, 2022

News Daily News

Journal of Cardiac Failure Launches Rapid Publication Platform to Spark Discourse

Todd Neale

January 21, 2022

Advertisement

Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term

SODIUM-HF: No Impact of Tighter Dietary Salt Restriction on Death or Hospitalization

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

April 2022 News Roundup

A ‘Call to Action’ for HF Trials: More Black, Hispanic Patients

Prognosis of Myocarditis Following COVID-19 Vaccination ‘Favorable’

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

Heart Transplant Recipients Fare Poorer When Stroke Is Cause of Death for Younger Donors

Guideline-Directed Therapies Underused in Frail HF Patients

March 2022 News Roundup

TCTMD’s Top 10 Most Popular Stories for February 2022

FDA Approves Empagliflozin for Treatment of HFpEF

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

PA Pressure Monitoring Useful Even in Presymptomatic CHF Patients

Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size

Hemodynamic Profiles Across the Range of Left Ventricular Ejection Fraction in Heart Failure With Preserved Ejection Fraction – Potential Therapeutic Implications

Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients

The Effect of Rhythm vs. Rate Control for Atrial Fibrillation on Mortality and Hospitalization in Patients With Heart Failure With Preserved Ejection Fraction: Updated Meta-Analysis

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Journal of Cardiac Failure Launches Rapid Publication Platform to Spark Discourse

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content